InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
tedkov Free
03/13/19 11:08 AM
profile icon
spsiege Free
01/31/19 4:26 PM
profile icon
Renee PremiumMember
08/02/18 9:17 AM
profile icon
sabadollar Free
07/01/18 1:46 AM
profile icon
Logon26 Free
03/29/18 3:48 AM
profile icon
Logon26 Free
03/23/18 1:51 PM
profile icon
sabadollar Free
02/26/18 2:02 PM
profile icon
stocktrademan Free
11/25/17 12:44 PM
profile icon
Renee PremiumMember
11/06/17 9:32 AM
profile icon
stocktrademan Free
03/15/17 11:34 AM
profile icon
Renee PremiumMember
03/14/17 8:11 PM
profile icon
willlbone Free
03/14/17 3:14 PM
profile icon
3ch0 Free
12/02/16 5:26 PM
profile icon
3ch0 Free
11/22/16 9:11 PM
profile icon
3ch0 Free
11/19/16 1:56 PM
profile icon
3ch0 Free
11/17/16 8:58 PM
profile icon
3ch0 Free
11/14/16 2:45 PM
profile icon
Randle Clint Free
11/14/16 10:34 AM
profile icon
3ch0 Free
11/13/16 8:18 PM
profile icon
Randle Clint Free
11/10/16 5:35 PM
profile icon
ClayTrader Free
11/08/16 5:16 PM
profile icon
3ch0 Free
09/19/16 7:40 PM
profile icon
3ch0 Free
09/15/16 8:17 AM
profile icon
3ch0 Free
09/13/16 2:37 PM
profile icon
spsiege Free
09/12/16 5:05 PM
profile icon
3ch0 Free
09/09/16 5:50 PM
profile icon
3ch0 Free
09/09/16 5:49 PM
profile icon
spsiege Free
09/09/16 5:01 PM
profile icon
3ch0 Free
09/08/16 6:58 PM
profile icon
3ch0 Free
09/05/16 4:53 PM
profile icon
3ch0 Free
09/03/16 5:24 PM
profile icon
BananaApes Free
09/03/16 6:22 AM
profile icon
3ch0 Free
09/02/16 1:08 PM
profile icon
3ch0 Free
08/29/16 6:58 PM
profile icon
3ch0 Free
08/26/16 7:05 PM
profile icon
3ch0 Free
08/22/16 7:04 PM
profile icon
3ch0 Free
08/21/16 3:33 PM
profile icon
3ch0 Free
08/18/16 9:20 PM
profile icon
3ch0 Free
08/12/16 7:44 PM
profile icon
JefftDecker Free
08/08/16 9:31 AM
profile icon
JefftDecker Free
08/08/16 9:31 AM
profile icon
JefftDecker Free
08/05/16 1:56 PM
profile icon
JefftDecker Free
08/05/16 9:59 AM
profile icon
spsiege Free
08/04/16 10:34 PM
profile icon
JefftDecker Free
08/04/16 5:22 PM
profile icon
JefftDecker Free
08/04/16 9:14 AM
profile icon
3ch0 Free
08/04/16 8:05 AM
profile icon
JefftDecker Free
08/03/16 10:50 AM
profile icon
JefftDecker Free
08/03/16 6:53 AM

Osiris Therapeutics Inc. (OSIR) RSS Feed

Followers
29
Posters
65
Posts (Today)
0
Posts (Total)
268
Created
08/28/07
Type
Free
Moderators

Osiris Therapeutics, Inc (OSIR) 

 

 

 

http://www.osiristx.com/

 

 

 

 

Company Address:

7015 Albert Einstein Drive
Columbia, MD 21046

Phone: 443.545.1800
Fax: 443.545.1701
Directions Map
E-mail:
Osiris@Osiris.com

 

CIK:  0001360886

 

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris' stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation.

 

Management: 

 

C. Randal Mills, Ph.D., President and Chief Executive Officer

Philip R. Jacoby, Jr., Chief Financial Officer and Corporate Secretary

Michelle LeRoux Williams, Ph.D., Chief Scientific Officer

Lode Debrabandere, Ph.D., Senior Vice President, Therapeutics

Stephen W. Potter, Senior Vice President of Operations and Corporate Development

Douglas Jacobstein, M.D., Senior Director, Medical Affairs

Christopher R. Alder, J.D., Chief Intellectual Property Counsel

 

Important Company Highlights: 

 

 

Prochymal is being evaluated in Phase 3 clinical trials for several indications, including acute graft versus host disease (GvHD) and also Crohn's disease, and is the only stem cell therapeutic currently designated by the FDA as both an Orphan Drug and Fast Track product.

Prochymal is also being developed for the repair of heart tissue following a heart attack, the protection of pancreatic islet cells in patients with type 1 diabetes, and the repair of lung tissue in patients with pulmonary disease.

Osiris has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies.

Chondrogen is currently being evaluated in clinical trials for the treatment of osteoarthritis in the knee. Enrollment for this trial has been completed.

 

Recent News: 

http://finance.yahoo.com/q/h?s=ODP+Headlines

 

 

Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=osir&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

 

Transfer Agent:

Stocktrans, Inc.

44 W Lancaster Ave

Ardmore, PA 19003

610.649.7300

 

 

Share Structure:

Outstanding Shares

32,790,019 as of Nov 4, 2010

 

Authorized Shares

90,000,000 as of Sept 30, 2010

 

Investor Relations:

Erica Elchin
Phone: 443.545.1834
E-mail:
OsirisPR@Osiris.com

 

 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

 

 

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
OSIR Latest News
  • No Recent News Available for this company!
New Post